Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05953194 · ClinicalTrials.gov registry record · NA

Effects of Sugary Drinks Counter-marketing Messages

A NA study of Obesity and Weight Gain, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
2,184
Enrollment target
1
Study location

NCT05953194 is a NA study of Obesity and Weight Gain that has completed, run by Stanford University. The registered enrollment target is 2,184 participants, above the 817-participant average among 1,053 other Obesity trials with a reported enrollment target (167% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05953194, a NA study of Obesity and Weight Gain, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
2,184 participants
Enrollment target
1
Study location

Study Summary

This study aims to examine consumer responses to traditional and counter-marketing messages discouraging sugary drink consumption, including effects on intentions to consume sugary drinks and perceived weight stigma. Because prior research has suggested that counter-marketing may be especially effective among younger populations, the investigators will examine effects overall and by age group (young adults \[ages 18-29 years\] vs. middle and older adults \[ages 30+ years\]).

Interventions

  • BEHAVIORAL Exposure to counter-marketing messages
  • BEHAVIORAL Exposure to traditional health messages
  • BEHAVIORAL Exposure to control (neutral) messages

Study Locations (1)

California

  • Stanford School of Medicine - Palo Alto

Trial Details

FieldValue
Enrollment Target 2,184 participants
Start Date 2023-08-07
Est. Completion 2023-08-07
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT05953194

The ClinicalTrials.gov registry entry for NCT05953194 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,184 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 817-participant average among 1,053 other Obesity trials with a reported enrollment target (167% higher). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Exposure to counter-marketing messages is the first listed.

NCT05953194 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05953194 about?

NCT05953194 is a clinical study titled "Effects of Sugary Drinks Counter-marketing Messages". This study aims to examine consumer responses to traditional and counter-marketing messages discouraging sugary drink consumption, including effects on intentions to consume sugary drinks and perceived weight stigma. Because prior research has suggested that counter-marketing may be especially effec...

What is the current status of trial NCT05953194?

This trial is currently completed. It is a NA study. The enrollment target is 2,184 participants. The study started on 2023-08-07. Estimated completion is 2023-08-07.

What conditions does trial NCT05953194 study?

This clinical trial studies the following conditions: Obesity, Weight Gain, Dietary Habits, Weight Prejudice.

What interventions are being tested in trial NCT05953194?

The interventions under investigation include: Exposure to counter-marketing messages (BEHAVIORAL), Exposure to traditional health messages (BEHAVIORAL), Exposure to control (neutral) messages (BEHAVIORAL).

Who is sponsoring clinical trial NCT05953194?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05953194 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.